1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base and Forecast Years Timeline
1.8. Key Benefits to the Stakeholder
2. RESEARCH METHODOLOGY
2.1. Research Design
2.2. Research Processes
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
4.5. Analyst View
5. GLOBAL DERMATOLOGICAL DRUG MARKET BY INDICATION
5.1. Introduction
5.2. Psoriasis
5.2.1. Market Opportunities and Trends
5.2.2. Growth Prospects
5.2.3. Geographic Lucrativeness
5.3. Acne
5.3.1. Market Opportunities and Trends
5.3.2. Growth Prospects
5.3.3. Geographic Lucrativeness
5.4. Dermatitis
5.4.1. Market Opportunities and Trends
5.4.2. Growth Prospects
5.4.3. Geographic Lucrativeness
5.5. Others
5.5.1. Market Opportunities and Trends
5.5.2. Growth Prospects
5.5.3. Geographic Lucrativeness
6. GLOBAL DERMATOLOGICAL DRUG MARKET BY ROUTE OF ADMINISTRATION
6.1. Introduction
6.2. Topical
6.2.1. Market Opportunities and Trends
6.2.2. Growth Prospects
6.2.3. Geographic Lucrativeness
6.3. Oral
6.3.1. Market Opportunities and Trends
6.3.2. Growth Prospects
6.3.3. Geographic Lucrativeness
6.4. Parenteral
6.4.1. Market Opportunities and Trends
6.4.2. Growth Prospects
6.4.3. Geographic Lucrativeness
7. GLOBAL DERMATOLOGICAL DRUG MARKET BY END-USER
7.1. Introduction
7.2. Hospitals And Clinics
7.2.1. Market Opportunities and Trends
7.2.2. Growth Prospects
7.2.3. Geographic Lucrativeness
7.3. Cosmetic Centers
7.3.1. Market Opportunities and Trends
7.3.2. Growth Prospects
7.3.3. Geographic Lucrativeness
7.4. Others
7.4.1. Market Opportunities and Trends
7.4.2. Growth Prospects
7.4.3. Geographic Lucrativeness
8. GLOBAL DERMATOLOGICAL DRUG MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. By Indication
8.2.2. By Route of Administration
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. USA
8.2.4.1.1. Market Opportunities and Trends
8.2.4.1.2. Growth Prospects
8.2.4.2. Canada
8.2.4.2.1. Market Opportunities and Trends
8.2.4.2.2. Growth Prospects
8.2.4.3. Mexico
8.2.4.3.1. Market Opportunities and Trends
8.2.4.3.2. Growth Prospects
8.3. South America
8.3.1. By Indication
8.3.2. By Route of Administration
8.3.3. By End-User
8.3.4. By Country
8.3.4.1. Brazil
8.3.4.1.1. Market Opportunities and Trends
8.3.4.1.2. Growth Prospects
8.3.4.2. Argentina
8.3.4.2.1. Market Opportunities and Trends
8.3.4.2.2. Growth Prospects
8.3.4.3. Others
8.3.4.3.1. Market Opportunities and Trends
8.3.4.3.2. Growth Prospects
8.4. Europe
8.4.1. By Indication
8.4.2. By Route of Administration
8.4.3. By End-User
8.4.4. By Country
8.4.4.1. Germany
8.4.4.1.1. Market Opportunities and Trends
8.4.4.1.2. Growth Prospects
8.4.4.2. France
8.4.4.2.1. Market Opportunities and Trends
8.4.4.2.2. Growth Prospects
8.4.4.3. United Kingdom
8.4.4.3.1. Market Opportunities and Trends
8.4.4.3.2. Growth Prospects
8.4.4.4. Spain
8.4.4.4.1. Market Opportunities and Trends
8.4.4.4.2. Growth Prospects
8.4.4.5. Others
8.4.4.5.1. Market Opportunities and Trends
8.4.4.5.2. Growth Prospects
8.5. Middle East and Africa
8.5.1. By Indication
8.5.2. By Route of Administration
8.5.3. By End-User
8.5.4. By Country
8.5.4.1. Saudi Arabia
8.5.4.1.1. Market Opportunities and Trends
8.5.4.1.2. Growth Prospects
8.5.4.2. South Africa
8.5.4.2.1. Market Opportunities and Trends
8.5.4.2.2. Growth Prospects
8.5.4.3. Israel
8.5.4.3.1. Market Opportunities and Trends
8.5.4.3.2. Growth Prospects
8.5.4.4. Others
8.5.4.4.1. Market Opportunities and Trends
8.5.4.4.2. Growth Prospects
8.6. Asia Pacific
8.6.1. By Indication
8.6.2. By Route of Administration
8.6.3. By End-User
8.6.4. By Country
8.6.4.1. China
8.6.4.1.1. Market Opportunities and Trends
8.6.4.1.2. Growth Prospects
8.6.4.2. Japan
8.6.4.2.1. Market Opportunities and Trends
8.6.4.2.2. Growth Prospects
8.6.4.3. Thailand
8.6.4.3.1. Market Opportunities and Trends
8.6.4.3.2. Growth Prospects
8.6.4.4. Indonesia
8.6.4.4.1. Market Opportunities and Trends
8.6.4.4.2. Growth Prospects
8.6.4.5. South Korea
8.6.4.5.1. Market Opportunities and Trends
8.6.4.5.2. Growth Prospects
8.6.4.6. India
8.6.4.6.1. Market Opportunities and Trends
8.6.4.6.2. Growth Prospects
8.6.4.7. Taiwan
8.6.4.7.1. Market Opportunities and Trends
8.6.4.7.2. Growth Prospects
8.6.4.8. Others
8.6.4.8.1. Market Opportunities and Trends
8.6.4.8.2. Growth Prospects
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. AbbVie Inc
10.2. Amgen Inc
10.3. GlaxoSmithKline Plc
10.4. Johnson & Johnson
10.5. Leo Pharma A/S
10.6. Merck KGaA
10.7. Nestlé S.A
10.8. Novartis AG
10.9. Pfizer Inc
10.10. Curatio Healthcare